OXMIQ Labs
Develops licensable GPU architecture and AI infrastructure software for custom AI silicon
$35MSeries A
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops licensable GPU architecture and AI infrastructure software for custom AI silicon
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases
Discovers and engineers novel enzymes and microbial strains for bio-based products using AI